Welcome to MAPS canada
Working with partners in government, business and community, MAPS Canada positions itself as the leading resource in the field of psychedelic medicine through multi-disciplinary research, public education and the training of psychedelic therapists.
Psychedelics are back and they offer transformation in a world that desperately needs it.
Current research with psychedelics is yielding promising results in the treatment of trauma, end of life anxiety, depression and addiction. This wave of resurgence has not come about by chance. At the heart of this psychedelic renaissance is a solid foundation of rigorous scientific studies on these substances and MAPS Canada is the organization that has been spearheading a lot of this important work in Canada.
Currently, MAPS Canada has been supporting studies to legalize MDMA-assisted psychotherapy for the treatment of post-traumatic stress disorders which are now entering into the final phases of clinical trials.
New Psychedelic Use Survey
This survey is sponsored by MAPS Canada and the University of British Columbia – Department of Psychology. We have the goal of developing psychedelics into legal medicines, through the process of clinical trial research, which often begins with understanding what is happening with the use of psychedelics in the community. Therefore, the purpose of this survey is to collect data which will be analyzed and (hopefully) published in a research journal. This survey is anonymous so no identifying information (e.g. name, address, birth date etc.) is collected, stored or shared.
This survey is structured to collect information on the details of your experiences with for a wide variety of different psychedelics. Completion of this survey should take less than 15-30 minutes.
Thank you for participating – we hope your contribution will help produce legal access to these important medicines.
In collaboration with...
